Toronto Stocks Advance; Tilray Brands Down on Outlook Cut, 3Q Misses
By Adriano Marchese
Toronto-listed stocks were slightly higher mid-trading Tuesday after dipping lower mid-morning. Investors are awaiting Wednesday's Bank of Canada decision on interest rates where analysts predict the central bank will hold rates steady for a sixth consecutive meeting.
Sector performance was mixed in Canada. Health tech logged the most losses in the session, followed more distantly by process industries and materials. These were offset by gains mainly in commercial services, retail and industrial services.
At midday, Canada's S&P/TSX Composite Index was up by 0.2% to 22298.22 and the blue-chip S&P/TSX 60 rose by 0.2% to 1336.33.
Tilray Brands' Toronto-listed shares were down 20% to 2.81 Canadian dollars ($2.07) after the company cut its outlook and warned of delays in collecting cash on various asset sales, preventing the cannabis company from generating positive adjusted free cash flow for the year. In the third quarter, the company missed expectations on loss and revenue growth.
Other market movers:
Galaxy Digital stock fell more than 18% to C$13.14 a share after the digital asset and blockchain company moved to raise roughly $125 million by way of a bought deal public stock offering.
Shares in BlackBerry rose by 8.7% to C$4.25 after the company said it has partnered with chipmaking giant AMD to develop robotic systems.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
April 09, 2024 12:25 ET (16:25 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks